Sequential Therapy With WLL/Inhaling GM-CSF for Autoimmune Pulmonary Alveolar Proteinosis
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03316651 |
|
Recruitment Status : Unknown
Verified September 2017 by Dai Huaping, China-Japan Friendship Hospital.
Recruitment status was: Recruiting
First Posted : October 20, 2017
Last Update Posted : October 20, 2017
|
Sponsor:
Dai Huaping
Information provided by (Responsible Party):
Dai Huaping, China-Japan Friendship Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | December 2019 |
| Estimated Study Completion Date : | December 2020 |